Ledger.Open graph →
SEC Form D · filed July 30, 2012

Ultragenyx Pharmaceutical Inc

Offering
$30.1M
Sold
$15.1M
Exemption
—
Industry
Biotechnology
Location
Novato, CA
Type
—

People & firms on this filing (9)

Ben Auspitz · Cambridge, MADirectorEran Nadav · San Francisco, CADirectorMarten Steen · Lausanne, V8DirectorEmil Kakkis · Novato, CAExec · DirectorPharmacy Portfolio Iii, L.L.C · Oak Brook, ILDirectorPharmacy Portfolio III Exchange, L.L.C · Oak Brook, ILDirectorThomas A. Lewis · Mesquite, TXDirectorEmil Kakkis · NOVATO, CAExec · DirectorWilliam Aliski · Novato, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗